Drug Profile
Levormeloxifene
Alternative Names: 6720 CDRI; Levomeloxifene; NNC 460020Latest Information Update: 15 Jan 2003
Price :
$50
*
At a glance
- Originator Central Drug Research Institute
- Developer Novo Nordisk; Novo Nordisk Pharma; Takeda
- Class Pyrrolidines
- Mechanism of Action Selective estrogen receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Postmenopausal osteoporosis